ASCEND PARTNERS
ASCEND PARTNERS is a Series C+ and buyout fund in the US investing in healthcare-tech, physician-services, value-based-care and healthcare-it.
- Stages
- Series C+, buyout
- Sectors
- healthcare-tech, physician-services, value-based-care, healthcare-it
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2019
- Assets under management
- $2.2B
- Website
- ascendpartners.com
Check size not disclosed
Thesis
Ascend Partners is a private equity firm founded in 2019, specializing in the US healthcare sector with a mission to improve healthcare access, affordability, and quality for underserved and vulnerable populations. Their investment thesis is rooted in personal experiences, aiming to partner with companies that enhance the lives of patients, physicians, and providers. They employ a growth-oriented approach, focusing on integrated, operational strategies to overcome care delivery fragmentation. Ascend Partners invests in physician and provider services, value-based care enablement companies, and healthcare IT. Their multi-strategy mandate includes growth equity, late-stage expansion, co-investments, and corporate restructurings. The firm has closed two funds: Ascend Capital Partners Fund I with $570 million and Ascend Capital Partners Fund II with $791 million. Regulatory filings indicate approximately $2.2 billion in regulatory assets under management. They focus on growth equity and late-stage expansion within the United States, particularly in underserved communities. The firm has a team of approximately 14-21 employees. Ascend Partners does not publicly disclose typical check sizes per investment deal or specific fund sizes beyond total capital commitments.
Common questions
Does ASCEND PARTNERS invest at the Series C+ stage?
Yes. ASCEND PARTNERS lists Series C+ and buyout among the stages it invests in.
Where does ASCEND PARTNERS invest?
ASCEND PARTNERS invests in the US.